Open, multi-center, phase IV study to assess the efficacy and tolerability of triptorelin in Taiwanese patients with advanced prostate cancer | Zendy

ChienChang Kao | Zendy; Yen-Hwa Chang | Zendy; Tony T. Wu | Zendy; GuangHuan Sun | Zendy; DahShyong Yü | Zendy; SunYran Chang | Zendy; TaiLung Cha | Zendy

Open Access

Open, multi-center, phase IV study to assess the efficacy and tolerability of triptorelin in Taiwanese patients with advanced prostate cancer

Author(s) -

ChienChang Kao,

Yen-Hwa Chang,

Tony T. Wu,

GuangHuan Sun,

DahShyong Yü,

SunYran Chang,

TaiLung Cha

Publication year - 2012

Publication title -

journal of the chinese medical association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.535

H-Index - 42

eISSN - 1728-7731

pISSN - 1726-4901

DOI - 10.1016/j.jcma.2012.04.010

Subject(s) - medicine , triptorelin , tolerability , prostate cancer , bicalutamide , adverse effect , urology , genitourinary system , constipation , cancer , hormone , gonadotropin releasing hormone , androgen receptor , luteinizing hormone

To evaluate the efficacy and safety of administering a 3-month formulation of triptorelin as part of disease management of Taiwanese men with advanced adenocarcinoma of the prostate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research